July 25, 2014 9:41 AM ET

Pharmaceuticals

Company Overview of Aerovance, Inc.

Company Overview

Aerovance, Inc., a biopharmaceutical company, engages in the development and commercialization of medicines for respiratory and allergic diseases. The company offers Aerovant, a novel molecule that targets the root cause of asthma by blocking Th2 allergic inflammation; Aeroderm, which is formulated for the treatment of atopic eczema; Aerolytic that is used for the treatment of cystic fibrosis; and Pulmolytic, which is used for the treatment of chronic obstructive pulmonary disease. Aerovance, Inc. was founded in 2004 and is based in Berkeley, California.

2929 7th Street

Suite 120

Berkeley, CA 94710

United States

Founded in 2004

Phone:

510-549-5500

Fax:

510-549-5501

Key Executives for Aerovance, Inc.

Chief Financial Officer and Vice President
Age: 50
Chief Technical Officer and Senior Vice President
Chief Commercial Officer and Executive Vice President
Age: 52
Chief Medical Officer and Senior Vice President
Age: 57
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Russ Pharmaceuticals United States
Foodscience Corporation United States
Apricus Pharmaceuticals USA, Inc. United States
MediNiche, Inc. United States
FreeStride Therapeutics Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Aerovance, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.